Obesity Year in Review: Major Advances and Discoveries
Explore this recorded session from the American Diabetes Association’s 2026 Scientific Sessions reviewing major advances in obesity care, including emerging medications, treatment maintenance, and strategies to balance weight loss with side effects and lean-mass changes. The talks also examine preclinical insights into drug action and obesity physiology, followed by a discussion of clinical guidance, personalized treatment, and future research priorities.
Overview
Explore this recorded session from the American Diabetes Association’s 2026 Scientific Sessions reviewing major advances in obesity care, including emerging medications, treatment maintenance, and strategies to balance weight loss with side effects and lean-mass changes. The talks also examine preclinical insights into drug action and obesity physiology, followed by a discussion of clinical guidance, personalized treatment, and future research priorities.
Learning Objectives
  • Evaluate how continuing, reducing, or stopping obesity medication affected weight maintenance in the trials discussed.
  • Distinguish treatment-policy estimates from efficacy estimates.
  • Assess the brainstem signaling mechanisms investigated in preclinical studies of GLP-1–based treatments.
  • Identify measures used to assess muscle function alongside lean-mass changes.
Faculty
Louis Aronne, MD, FACP, DABOM
Julio Ayala, PhD
Summary
Availability:
On-Demand
Expires on Jan 01, 2028
Cost:
FREE
Credit Offered:
No Credit Offered
Android App Download IOS App Download Powered By